The authors evaluated AKL-T03, an investigational digital intervention delivered through a video game–based interface, designed to target the fronto-parietal network to enhance functional domains for attentional control. AKL-T03 was tested in adult patients with major depressive disorder and a demonstrated cognitive impairment at baseline. To read the full article, log in using your MPFT NHS OpenAthens details.
The purpose of this study is to find out a simple cognitive intervention method to use MCI and suffering people with depression. As the elderly society increases around the world, the number of elderly people with diseases and dementia is increasing rapidly. Mild cognitive impairment (MCI), a pre-stage to dementia, is a critical treatment time to slow disease progression. However, there is currently no appropriate medication. Furthermore, MCI patients with depression are more difficult to treat.
To read the full article, log in using your NHS OpenAthens details.
Contrary to previous research, this study demonstrates that VC-delivered CBT is not a barrier to the establishment of a strong working alliance and successful treatment outcomes.
There is no evidence here that removing stepped care as an approach is clinically required or financially effective. Within the stratified care condition which contains personalised treatment recommendations, 50.9% of patients were still allocated to low-intensity treatments first. The training and financial burden to services of offering high-intensity interventions to all patients as a first line treatment for depression makes this recommendation unfeasible and is likely to lead to longer waits for treatment for all patients and unnecessarily so
This article explores men's experiences of using peer support groups for coping with mental distress. To read the full article, log in using your NHS OpenAthens details.
Most studies on the health impact of occupational stress use single-point measures of stress at work. This study analyses the associations of properties of entire employment trajectories over an extended time period with a composite score of allostatic load (AL). To read the full article, log in using your NHS OpenAthens details.
Development and use of the UP-C indicates a priority to move away from a medical model which requires formal diagnosis and toward more of a social/psychological model based around a joint formulation between the young person and therapist. The latter recognises the role of the system surrounding the young person and allows specific treatment to take place without the need of formal diagnosis and based on individual need. This can be helpful in ensuring our young people get the support that would help.
Findings from this review identify key clinical and psychological characteristics that place individuals at particular risk for developing persistent anxiety disorders.
The COVID-19 pandemic has had a significant impact on mental health. Specifically, the stringent lockdown restrictions have heightened anxiety and depression. Therefore, monitoring and supporting the mental health of the population during these unprecedented times is an immediate priority. To read the full article, log in using your MPFT NHS OpenAthens details.
Depression is one of the most common mental illnesses globally and a leading cause of disability. It is often established by late adolescence and thus identifying which adolescents are most at risk is crucial to enable early intervention to prevent depression onset. We have previously developed a risk calculator to stratify which adolescents are at high risk of developing depression and in this study explore the views of stakeholders to ascertain the acceptability and feasibility of implementing such a tool in the UK. To read the full article, log in using your MPFT NHS OpenAthens details.
Psychological interventions for depression/anxiety should target more and more diverse intrapersonal emotion regulation skills. More specifically, therapies focusing on improving engagement emotion regulation skills and reducing disengagement emotion regulation skills and emotion dysregulation seem particularly impactful. Additionally, long treatments with six or more sessions, cognitive behavioural therapies and group interventions should be favoured.
This paper highlights the need for more research, as there was little empirical evidence establishing the specific intervention mechanisms. With further investigation, this could support clinicians to refine existing interventions for depression and anxiety to ensure the most effective underlying mechanisms are incorporated into treatment plans.
The qualitative findings imply the importance of co-design and co-evaluation with young people using therapeutic services. It suggests that service-user forums are necessary to help clinicians identify treatment barriers, and therefore should be encouraged to ensure the best outcomes for service-user and service by designing the most effective interventions.
CBT treatment for children and young people with anxiety appears to be equally effective with and without family/parental involvement. This suggests that it is appropriate to offer both approaches to patients under the age of 17. In deciding which approach to offer it would be helpful to consider the child’s age and developmental level, as well as the child’s preferences. It’s likely that treatment adherence and engagement can be improved if the child feels their voice is heard and that their views are considered during treatment.
There is growing evidence that remote monitoring technologies are acceptable to young people and can collect data that is associated with and potentially predictive of depressive symptoms. However, there is a distinct lack of evidence for their impact on clinical outcomes (good or bad) and whether they can be implemented in the real-world,
CBT for grief (e.g., Boelen et al, 2021), of 10 sessions or more, in an individual format, with more than 50% of the intervention including specific CBT strategies, should be offered to grieving young people with symptoms of anxiety and depression.
T. Itatsu, A. Nagahara, M. Hojo, A. Miyazaki, T. Murai, M. Nakajima, and S. Watanabe. Internal medicine (Tokyo, Japan), 50 (7):
713-7(January 2011)JID: 9204241; 0 (Serotonin Uptake Inhibitors); 2011/04/01 epublish; ppublish; Confusió absoluta entre cas-control i exposats-no exposats<br/><br/><br/>Tipus d'estudis.